PARP Inhibitors: Assessing the Rapidly Evolving Treatment Landscape
AUAUniversity31 Maalis 2021

PARP Inhibitors: Assessing the Rapidly Evolving Treatment Landscape

This educational series is supported by independent educational grants from AstraZeneca and Merck. CME Available: https://auau.auanet.org/node/31198 Based on the documented need from the 2019 AUA global needs assessment in advanced prostate cancer, the AUA has produced a new series of educational offerings for the urologic care team focused on PARP inhibitors (PARPi). The first of three in the series PARP Inhibitors: Assessing the Rapidly Evolving Treatment Landscape will address the latest developments in PARPi treatments and advanced prostate cancer care. Upon completion of this activity, participants will be able to: 1. Review recommended criteria for genetic testing of prostate cancer patients and the options for testing these men. 2. Explain importance of testing for germline pathogenic variants and their implication for utilizing novel targeted therapies such as PARP inhibitors and for cascade testing among patient family members. 3. Identify men with BRCA1/2 pathogenic variants and variants in other key inherited syndromes, regarding their prostate cancer and other cancer risk, and implement strategies for cancer screening and management.

Jaksot(422)

AUA2018 Second Opinion Cases (ask the Guidelines!): Benign Prostatic Hyperplasia (BPH)

AUA2018 Second Opinion Cases (ask the Guidelines!): Benign Prostatic Hyperplasia (BPH)

Moderator(s) Kevin McVary, MD Southern Illinois University School of Medicine Panelist(s) Harris Foster, Jr., MD Yale University School of Medicine Charles Welliver, MD Albany Medical College Steve...

12 Helmi 201927min

AUA2018 Second Opinion Cases Testosterone Deficiency

AUA2018 Second Opinion Cases Testosterone Deficiency

Second Opinion Cases (Ask the Guidelines!): Testosterone Deficiency Moderator(s) John Mulhall, MD Memorial Sloan Kettering Cancer Center Panelist(s) Robert Brannigan, MD Northwestern University, Fei...

31 Tammi 201932min

AUA2018 Second Opinion Cases Erectile Dysfunction

AUA2018 Second Opinion Cases Erectile Dysfunction

AUA2018 Second Opinion Cases in Erectile Dysfunction Moderator(s) Lawrence Hakim, MD, FACS Panelist(s) Arthur Burnett, MD, MBA, FACS Christian Nelson, PhD Alan Shindel, MD, MAS

23 Tammi 201926min

AUA2018 Take Home Messages Bladder Cancer - Basic Science Malignant

AUA2018 Take Home Messages Bladder Cancer - Basic Science Malignant

AUA2018 Take Home Messages Bladder Cancer - Basic Science Malignant by American Urological Association

7 Tammi 201918min

AUA2018 Take Home Messages Kidney Cancer & Transplantation

AUA2018 Take Home Messages Kidney Cancer & Transplantation

AUA2018 Take Home Messages Kidney Cancer & Transplantation by American Urological Association

3 Tammi 201914min

AUA2018 Take Home Messages Female Urology Incontinence - QIPS

AUA2018 Take Home Messages Female Urology Incontinence - QIPS

AUA2018 Take Home Messages Female Urology Incontinence - QIPS by American Urological Association

31 Joulu 201826min

AUA2018 Take Home Messages Prostate Cancer - BPH LUTS

AUA2018 Take Home Messages Prostate Cancer - BPH LUTS

AUA2018 Take Home Messages Prostate Cancer - BPH LUTS by American Urological Association

19 Joulu 201823min

AUA2018 Take Home Messages Penile Urethral Cancer - Outcomes

AUA2018 Take Home Messages Penile Urethral Cancer - Outcomes

AUA2018 Take Home Messages Penile Urethral Cancer - Outcomes by American Urological Association

14 Joulu 201820min

Suosittua kategoriassa Koulutus

rss-murhan-anatomia
psykopodiaa-podcast
rss-narsisti
voi-hyvin-meditaatiot-2
rss-vapaudu-voimaasi
rss-liian-kuuma-peruna
aamukahvilla
psykologia
dear-ladies
leveli
adhd-podi
kesken
rss-duodecim-lehti
avara-mieli
rahapuhetta
aloita-meditaatio
ihminen-tavattavissa-tommy-hellsten-instituutti
rss-tietoinen-yhteys-podcast-2
filocast-filosofian-perusteet
rss-luonnollinen-synnytys-podcast